MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
6.30
-0.10 (-1.56%)
Apr 2, 2025, 4:11 PM CET

MaaT Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
--19.72-13.71-9.02-5.3
Upgrade
Depreciation & Amortization
-0.790.370.290.13
Upgrade
Other Amortization
-0.080.060.040.04
Upgrade
Stock-Based Compensation
-0.870.650.790.02
Upgrade
Other Operating Activities
--0.310.080.190.04
Upgrade
Change in Accounts Receivable
-0.35-0.32-0.39-
Upgrade
Change in Inventory
--0.14-0.01-0.03-
Upgrade
Change in Accounts Payable
-1.842.041.07-0.28
Upgrade
Change in Other Net Operating Assets
--2.43-1.75-0.86-0.48
Upgrade
Operating Cash Flow
--18.67-12.61-7.93-5.84
Upgrade
Capital Expenditures
--1.09-0.66-0.24-0.32
Upgrade
Investment in Securities
-0.01-0.2--0.18
Upgrade
Other Investing Activities
-0.640.05--
Upgrade
Investing Cash Flow
--0.44-0.82-0.24-0.49
Upgrade
Long-Term Debt Issued
--7.480.463.52
Upgrade
Long-Term Debt Repaid
--4.19-1.93-0.95-0.58
Upgrade
Net Debt Issued (Repaid)
--4.195.55-0.492.94
Upgrade
Issuance of Common Stock
-12.590.132.4417.95
Upgrade
Repurchase of Common Stock
--0.08-0.14--
Upgrade
Other Financing Activities
--0.18-0.15-0.1-0.05
Upgrade
Financing Cash Flow
-8.145.3631.5620.84
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0--
Upgrade
Net Cash Flow
--10.97-8.0623.3914.5
Upgrade
Free Cash Flow
--19.76-13.27-8.17-6.16
Upgrade
Free Cash Flow Margin
--887.03%-927.76%-840.23%-
Upgrade
Free Cash Flow Per Share
--1.74-1.34-3.37-5.97
Upgrade
Cash Interest Paid
-0.180.150.10.05
Upgrade
Levered Free Cash Flow
--11.1-8.04-4.99-4.57
Upgrade
Unlevered Free Cash Flow
--10.85-7.92-4.92-4.55
Upgrade
Change in Net Working Capital
--0.970.070.231.13
Upgrade
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.